Excellent News! Shareholder Update: Creative Med
Post# of 350
Shareholder Update: Creative Medical Technology Holdings, Inc. Extinguishes Additional Debt With Affiliate Company Converting To Restricted Common Shares
$136,003.00 is being converted to restricted common shares of stock in Creative Medical Technology Holdings, Inc.
We used the 30 day average VWAP (March 1-30, 2018) and added a premium of 20% to reach the conversion price of $0.0138 per share. Which is 9,855,290 restricted common shares of CELZ stock,
Both Timothy & Donald are looking out for the best interest in the company and shareholders alike!
Great move!
Next up
"May 18-20 we'll be at the American Urological Association (AUA) conference at booth 5870 presenting our CaverstemTM erectile dysfunction technology. Our team is excited and ready to go!"
https://www.prnewswire.com/news-releases/shar...28900.html
Aloha!